P1L1 POD 1 of LSCS known Bilateral mesial temporal sclerosis on Levipil 1gm BD clone am 5 mg BD septal 300mg BD locosamide BD carbamazepine 200mg BD can she breastfeed
Reading File
Checking Date & Time
Finding Sources
Finding Sources
Searching PubMed
antiepileptic drugs breastfeeding safety
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
I now have comprehensive data. Let me compile the full answer.
Breastfeeding Safety Assessment — POD1 LSCS, Bilateral Mesial Temporal Sclerosis
Short answer: Yes, she can and should be encouraged to breastfeed, with monitoring of the infant. No drug on her regimen is an absolute contraindication to lactation. Here is a drug-by-drug breakdown:
Drug-by-Drug Lactation Profile
| Drug | Her Dose | Excreted in Milk | Milk:Serum Ratio | AAP Rating | WHO Rating | Verdict |
|---|---|---|---|---|---|---|
| Levetiracetam (Levipil) | 1g BD | Yes | ~300% (very high) | No formal rating | No formal rating | ✅ Allow — "probably safe"; no long-term harm shown |
| Clonazepam (Clon) | 0.5mg BD | Yes | Moderate | No formal rating | No formal rating | ⚠️ Allow with monitoring — watch for sedation/poor feeding |
| Clobazam (Septal 300mg) | — | Yes | Moderate | No formal rating | Compatible; monitor if prolonged use | ✅ Allow with monitoring |
| Lacosamide | (dose unspecified, BD) | Yes | Unknown/limited data | No formal rating | No formal rating | ⚠️ Allow — data limited; monitor infant |
| Carbamazepine | 200mg BD | Yes | Low (~4–6% of maternal dose) | Usually compatible | Compatible; monitor infant for side effects | ✅ Safest on this list — extensively studied |
Key Evidence Points
-
Overall guidance: "Mothers with epilepsy should be encouraged to breast-feed unless there is evidence of drug effects on the infant, such as lethargy or poor feeding. Breastfeeding does not need to be discouraged for reasons related to the milk's content of anticonvulsant medication, and current guidelines do not recommend changing the treatment regimen to a drug that does not penetrate breast milk." — Creasy & Resnik's Maternal-Fetal Medicine
-
Levetiracetam has a milk:serum ratio of ~300% (highest of all ASMs) yet prospective studies in the NEAD cohort showed no significant adverse neurodevelopmental outcomes in breastfed infants at age 3 years IQ testing. — Harrison's Principles of Internal Medicine, 22e
-
Carbamazepine: Only 4–6% of maternal dose reaches the infant via milk. Categorized "usually compatible" by AAP and "compatible, monitor" by WHO. Rare case of neonatal cholestatic hepatitis reported with high exposure. — Kaplan & Sadock's
-
Clobazam + Clonazepam (two benzodiazepines): The concern is additive CNS/respiratory depression in the neonate, especially combined with levetiracetam's high milk transfer. Monitor for excessive sedation, poor feeding, respiratory depression.
-
Lacosamide: Secreted in breast milk (confirmed), but formal safety ratings are absent — limited case series suggest no major infant harm, but data are sparse.
Practical Recommendations
Permit breastfeeding and counsel the mother as follows:
- Start breastfeeding from POD1 — benefits of breast milk outweigh theoretical drug risks for this regimen.
- Watch the infant closely for:
- Excessive somnolence / difficult to rouse
- Poor latching / weak suck
- Respiratory depression (particularly relevant given clonazepam + clobazam combined)
- Poor weight gain
- If sedation occurs: temporarily stop breastfeeding and observe the infant for withdrawal symptoms (jitteriness, feeding difficulty). Do not abruptly stop the mother's AEDs.
- Neonatal monitoring: Neonatology review is advisable given polypharmacy (5 AEDs). Drug levels in infant serum can be obtained if clinical concern arises.
- Two benzodiazepines flag: Clonazepam 5mg BD + Clobazam 300mg BD together is a high combined benzodiazepine burden — clarify actual doses (300mg of clobazam would be unusual; standard doses are 5–40mg/day). If doses are correct, sedation risk in infant is significant.
- Timing feeds: Some guidelines suggest timing feeds to trough (just before next dose) to minimize peak drug transfer — practically difficult but possible for clobazam/clonazepam.
Note on "Septal 300mg"
This is likely clobazam (Clobazam brand name "Frisium/Urban/Septal" varies by region). If the dose is indeed 300mg, this is far above the usual therapeutic range (max ~40mg/day). Please verify — it may be 300 micrograms or a different agent entirely. If it is actually clobazam 300mg, this dose itself needs immediate review regardless of breastfeeding.
Bottom line: Encourage breastfeeding. The combination of polypharmacy warrants close infant observation, but no individual drug here is an absolute contraindication to lactation. — Creasy & Resnik's Maternal-Fetal Medicine, Table 66.1; Harrison's Principles of Internal Medicine 22e, p. 3471
Zeptol in breast feeding
Checking Date & Time
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Zeptol = Carbamazepine — here is the focused answer:
Zeptol (Carbamazepine) in Breastfeeding
✅ Safe to continue — one of the best-studied AEDs in lactation
Pharmacokinetic profile in breast milk
| Parameter | Data |
|---|---|
| Excreted in breast milk | Yes |
| Milk concentration | ~40% of maternal serum concentration |
| Neonatal blood level | Below conventionally detectable amount |
| Relative Infant Dose (RID) | 1.1–7.3% of maternal weight-adjusted dose |
| Protein binding | Moderate (~75%) — limits milk transfer |
RID <10% is the standard threshold considered safe for breastfeeding. Carbamazepine's RID of 1.1–7.3% is well within this safe range.
Regulatory / Guideline Ratings
| Body | Rating |
|---|---|
| AAP (American Academy of Pediatrics) | "Usually compatible" with breastfeeding |
| WHO | "Compatible; monitor infant for side effects" |
Reported Adverse Effects in Infants (rare)
From the Maudsley Prescribing Guidelines data:
- Hepatitis — 1 case (resolved on stopping breastfeeding)
- Transient hepatic dysfunction with hyperbilirubinaemia + elevated GGT — 1 case (resolved despite continued feeding)
- Seizure-like activity, drowsiness, irritability, high-pitched crying — 1 case (mother was on multiple agents, not carbamazepine alone)
- No adverse developmental effects — a prospective study of children exposed through breast milk showed no difference in IQ at age 3 years vs non-breastfed infants
Bottom Line
Breastfeeding on Zeptol (carbamazepine) is permitted and encouraged. It is one of the safest anticonvulsants for lactation, with the lowest milk transfer among the drugs in this patient's regimen (far less than levetiracetam at 300% milk:serum ratio).
Monitor the infant for:
- Jaundice / cholestatic jaundice (liver function if clinically suspected)
- Sedation or irritability
- Poor feeding
No dose adjustment or feeding schedule modification is required. — Adams & Victor's Principles of Neurology 12e; Creasy & Resnik's MFM Table 66.1; Maudsley Prescribing Guidelines 15e, Table 7.4
This is a shared conversation. Sign in to Orris to start your own chat.